Optimal Strategy for Antiplatelet Therapy After Coronary Drug-Eluting Stent Implantation in High-Risk “TWILIGHT-like” Patients With Diabetes Mellitus

Optimal Strategy for Antiplatelet Therapy After Coronary Drug-Eluting Stent Implantation in High-Risk “TWILIGHT-like” Patients With Diabetes Mellitus

Background: Patients with diabetes mellitus (DM) are known to be at high-risk for both ischemic and bleeding complications post-percutaneous coronary intervention (PCI). The ischemic benefit vs. bleeding risk associated with extended dual antiplatelet therapy (DAPT) in high-risk “TWILIGHT-like” pati...

Full description

Bibliographic Details
Main Authors: Hao-Yu Wang, Zhong-Xing Cai, Dong Yin, Wei-Hua Song, Lei Feng, Run-Lin Gao, Yue-Jin Yang, Ke-Fei Dou
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-11-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
diabetes mellitus
dual antiplatelet therapy
high-risk patients
bleeding
thrombosis
drug-eluting stents
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2020.586491/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2020.586491/full

Similar Items